Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research – Chula Vista is part of the broader Velocity Clinical Research network, operating as an integrated clinical trial site in Southern California. The center conducts Phase I–IV clinical trials across multiple therapeutic areas, including vaccines, infectious diseases, internal medicine, endocrinology, and other chronic conditions. By being part of a large, centralized site network, the Chula Vista location benefits from standardized regulatory processes, experienced research staff, and streamlined study execution. The site supports pharmaceutical and biotechnology sponsors with patient recruitment, study coordination, regulatory compliance, and high-quality data collection. Its location in a diverse community enables access to varied patient populations, strengthening enrollment efficiency and representation in clinical research. The facility follows Good Clinical Practice (GCP) guidelines and prioritizes participant safety, ethical standards, and protocol…

Business Status

Source: Google. OPEN

Business Category

Source: Google. Medical clinic

Business Subcategory

Source: Google. Medical clinic
Source: Trial-derived.
20Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
1Active Trials
Source: Trial-derived.
16Completed Trials
Source: Trial-derived.
17Unique Conditions
Source: Trial-derived.
17Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Nonalcoholic Steatohepatitis (4)Source: Trial-derived. COVID-19 Pneumonia (2)Source: Trial-derived. Heartburn (2)Source: Trial-derived. Non-Alcoholic Steatohepatitis (2)Source: Trial-derived. Non-Erosive Gastro-Esophageal Reflux Disease (2)Source: Trial-derived. Acute Bacterial Skin and Skin Structure Infections (1)Source: Trial-derived. COVID-19 (1)Source: Trial-derived. Erosive Esophagitis (1)

Sponsors

Source: Trial-derived. Phathom Pharmaceuticals, Inc. (4)Source: Trial-derived. Gilead Sciences (3)Source: Trial-derived. Basilea Pharmaceutica (2)Source: Trial-derived. Enanta Pharmaceuticals, Inc (2)Source: Trial-derived. Janssen Vaccines & Prevention B.V. (2)Source: Trial-derived. Pfizer (2)Source: Trial-derived. Biomedical Advanced Research and Development Authority (1)Source: Trial-derived. CoLucid Pharmaceuticals (1)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PBMC isolation & cryopreservation

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic participant diary (eDiary/ePRO)
Source: AI-inferred. 13C urea breath test
Source: AI-inferred. ELISpot assay
Source: AI-inferred. Electronic patient-reported outcome diary (ePRO)
Source: AI-inferred. Helicobacter pylori antimicrobial susceptibility testing
Source: AI-inferred. Virus neutralisation antibody assay
Source: AI-inferred. Virus neutralisation assay